Daniel Nadler

Daniel J. Nadler
Born1983
Toronto, Ontario, Canada
CitizenshipCanadian
EducationHarvard University (PhD)
Occupations
  • Entrepreneur
  • poet
  • artist
OrganizationOpenEvidence
TitleFounder and CEO
Board member of

Daniel J. Nadler (born 1983) is a Canadian-born billionaire entrepreneur and poet. He is the founder and CEO of OpenEvidence, an artificial intelligence company that develops a medical search and clinical decision-support platform for physicians. He previously founded Kensho Technologies, which was acquired by S&P Global in 2018.

Nadler's debut poetry collection, Lacunae: 100 Imagined Ancient Love Poems (2016), was described by The Washington Post as a "striking debut". He was included in the Time 100 Health list of the 100 most influential individuals in global health. As of 2026, Forbes estimated his net worth was at US$7.6 billion.

Early life

Daniel Nadler was born in Toronto, Ontario, the son of immigrants from Poland and Romania. His father was an engineer who specialized in using sound to detect microscopic cracks in structures like bridges and submarines. Nadler attended Harvard University where he studied mathematics and classics, and poetry under the mentorship of Pulitzer Prize winner Jorie Graham. In 2016 Nadler received a PhD, also from Harvard, with a doctoral thesis on the pricing mechanisms of credit derivatives. He was a visiting scholar at the Federal Reserve during his PhD studies.

Career

Kensho Technologies

In 2013, while a PhD student, Nadler co-founded (with Peter Kruskall) Kensho Technologies, an artificial intelligence company that developed machine learning systems. The software allows a user to perform financial analysis like a google search engine. Nadler leased it to Wall Street asset managers. In 2018 Kensho was acquired by S&P Global for US$550 million.

Literary and artistic work

Nadler's debut collection of poetry, Lacunae: 100 Imagined Ancient Love Poems, was published by the American book publishing company Farrar, Straus and Giroux in 2016.

In film, Nadler has served as a financier and producer. He was a co-financier and producer on the 2021 drama Palmer starring Justin Timberlake, and served as an executive producer on the film Motherless Brooklyn (2019).

OpenEvidence

In 2021 Nadler founded OpenEvidence, an artificial intelligence company providing medical search and clinical decision support for physicians.

By early 2026, following several private funding rounds, the company reached a valuation of US$12 billion. Following several private funding rounds, the company reached a valuation of US$12 billion in January 2026.

Recognition

On May 8, 2025, Nadler was listed in the TIME100 Health list of the 100 most influential individuals in global health. In 2026, he was named to TIME Magazine's TIME100 AI list, which recognizes the 100 influential individuals in artificial intelligence.

Personal life

As of 2026, Nadler resides in Surfside, Florida. According to Forbes, his estimated net worth was approximately US $7.6 billion.

References

  1. 1 2 3 "Can Kensho Bring Google Style Search To Stock Picking?". Forbes. May 7, 2014. Retrieved 2016-04-02.
  2. ↑ Donnelly, Timothy. "The Doors of Perception". Boston Review. ISSN 0734-2306. Retrieved 2016-03-19.
  3. ↑ Popper, Nathaniel (2016-02-25). "The Robots Are Coming for Wall Street". The New York Times. ISSN 0362-4331. Retrieved 2016-03-19.
  4. ↑ "Daniel Nadler". Forbes. Retrieved 2025-07-19.
  5. ↑ CNBC Television (2025-02-19). Meet OpenEvidence, the 'ChatGPT' for verified doctors. Retrieved 2025-05-10 – via YouTube.
  6. ↑ Gara, Antoine. "Wall Street Tech Spree: With Kensho Acquisition S&P Global Makes Largest A.I. Deal In History". Forbes. Retrieved 2018-05-18.
  7. ↑ Lund, Elizabeth (2016-08-09). "See the world through these four poets' eyes". The Washington Post. ISSN 0190-8286. Retrieved 2026-10-12.
  8. 1 2 Park, Alice (May 8, 2025). "TIME100 Health 2025 TIME". TIME Magazine.
  9. 1 2 Shrivastava, Rashi. "AI Founder Daniel Nadler Is Twice As Rich After OpenEvidence Hits $12 Billion Valuation". Forbes. Archived from the original on 2026-01-27. Retrieved 2026-03-12.
  10. ↑ "Can Kensho Bring Google Style Search To Stock Picking?". Forbes. May 7, 2014. Retrieved 2016-04-02.
  11. ↑ Gara, Antoine. "Wall Street Tech Spree: With Kensho Acquisition S&P Global Makes Largest A.I. Deal In History". Forbes. Retrieved 2018-05-18.
  12. ↑ Macmillan. "Lacunae | Daniel Nadler | Macmillan". Macmillan. Retrieved 2016-03-19.
  13. ↑ "NPR's Book Concierge". NPR.org. Retrieved 2017-01-17.
  14. ↑ McNary, Dave (2020-07-15). "Justin Timberlake Drama 'Palmer' Bought by Apple". Variety. Retrieved 2026-02-22.
  15. ↑ "Justin Timberlake to Star in Homecoming Drama 'Palmer'". The Hollywood Reporter. 5 September 2019. Retrieved 2019-10-26.
  16. ↑ "Brand New Trailer for Edward Norton's 'Motherless Brooklyn'". Awards Daily. Retrieved 2026-02-22.
  17. ↑ "OpenEvidence". OpenEvidence. Retrieved 2025-05-27.
  18. ↑ CNBC Television (2025-02-19). Meet OpenEvidence, the 'ChatGPT' for verified doctors. Retrieved 2025-05-10 – via YouTube.
  19. ↑ Feldman, Amy. "OpenEvidence Cofounder Daniel Nadler Is Now A Billionaire". Forbes. Retrieved 2025-07-19.
  20. ↑ Bellan, Rebecca (2025-10-20). "OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation". TechCrunch. Retrieved 2025-11-20.
  21. ↑ "Medical AI startup OpenEvidence doubles valuation to $12 billion in latest round". EnterpriseAI (from The Economic Times). 2026-01-22.
  22. ↑ Kate Rooney (January 21, 2026). "OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion". CNBC. Retrieved January 26, 2026.
  23. ↑ Rooney, Kate (2026-01-21). "OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion". CNBC. Retrieved 2026-10-28.
  24. ↑ www.ETEnterpriseai.com. "Medical AI startup OpenEvidence doubles valuation to $12 billion in latest round". ETEnterpriseai.com. Retrieved 2026-10-28.
  25. ↑ "TIME Reveals the 2026 TIME100 AI List of the World's Most Influential People in Artificial Intelligence". Time. 2026-08-27. ISSN 0040-781X. Retrieved 2026-09-18.